3 ms·
I'm pretty certain this has nothing to do with pressure. The risks profile is very different, and for the same reason my trials aren't run on pregnant women. I
by TotempaaltJ 6y ago
I'm pretty certain this has nothing to do with pressure.
The risks profile is very different, and for the same reason my trials aren't run on pregnant women. It hardly makes sense (and would be immoral) to include people in a clinical trail who you know are more likely to get adverse affects (up to death) from the drug/vaccine.
Especially for vaccines you know there will be certain subgroups that can't be vaccinated anyway, and because of herd immunity that doesn't matter too much.
- mittermayr 6y agoWhy let those subgroups participate in the first vaccinations though? If they were clearly aware of this, why go ahead in one of the most-watched "deployments" (in my life-time), and invite the potential risk (and it's a huge risk) in only after it's gone "live" with the real population? I mean, if I knew those subgroups would be problematic, I sure as hell would make sure the first week of those vaccinations would go as smooth as possible (with all the media and the rest of humanity carefully watching), and give it to people I am most certain will be fine with it. Everything else, the trials should've caught, or should catch in the near future? Why play the risk on day one?!
- rsynnott 6y agoWhile they haven't said yet, it's fairly clear this was an error; either the people with a history of allergies ignored the warnings (every vaccine I've had as an adult has come with allergy warnings) or the warnings weren't given (which would be bad and must be fixed).